Pharmacogenetic markers of steroid dependent bronchial asthma (BA) control Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010
Influence of basic therapy of bronchial asthma (BA) on respiratory symptoms in patients with pulmonary TB associated with bronchial asthma Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014
The influence of inhalation device for bronchodilators on the results of therapy in primary care patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Asthma control or asthma severity Year: 2008
The glucocorticoid therapy influence on the lung microcirculation in patients with bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 353s Year: 2005
Bronchophonographia (BPG) in evaluation of lung function in children with bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 496s Year: 2003
Longitudinal change in bronchial responsiveness in patients with cough variant asthma and the effect of inhaled corticosteroids Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004
Current control, airway inflammation, and subsequent exacerbation in patients with asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010
Changes in symptoms, respiratory function, airway inflammation, and airway hyperresponsiveness over 10 year of inhaled corticosteroid therapy in adult asthma patients Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
Effect of montelukast on excessive airway narrowing in adult asthmatics not on controller therapy Source: Annual Congress 2006 - New developments in the treatment and management of asthma Year: 2006
Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial Source: Eur Respir J 2007; 30: 457-466 Year: 2007
A comparison of clinical characteristics between cough variant asthma (CVA) and bronchial asthma (BA) in adult patients Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010
Effects of inhaled salbutamol on autonomic control of heart rate in patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 58s Year: 2002
Assessment of bronchodilator reversibility in patients with bronchiectasis (BE) Source: Eur Respir J 2001; 18: Suppl. 33, 134s Year: 2001
Risk of bronchiectasis in bronchial asthma: steroid-dependent versus non-steroid-dependent asthma Source: Eur Respir J 2005; 26: Suppl. 49, 508s Year: 2005
The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Airway remodelling augmented in patients with asthma COPD overlap (ACO) compared to asthma and COPD. Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021
Indirect comparison of bronchial thermoplasty (BT) versus omalizumab (OM) for severe uncontrolled asthma Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
Metabolic differences in bronchial epithelium from asthma patients and impact of bronchial thermoplasty Source: Virtual Congress 2020 – Metabolic alterations and ageing in lung disease Year: 2020
Influence of natural lung surfactant inhalations on clinical symptoms and pulmonary function parameters in patients with bronchial asthma Source: International Congress 2018 – Does asthma phenotyping improve treatment? Year: 2018
Salmeterol/fluticasone propionate combination (SFC) improves airways hyperresponsiveness (AHR), lung function and symptoms in adult patients with mild asthma Source: Eur Respir J 2004; 24: Suppl. 48, 262s Year: 2004